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Abstract 29 
Deficits in impulse control are related to a number of psychiatric diagnoses, including ADHD, 30 
addiction and pathological gambling. Despite increases in our knowledge about the underlying 31 
neurochemical and neuroanatomical correlates, understanding of the molecular and cellular 32 
mechanisms is less well established. Understanding these mechanisms is essential in order to 33 
move towards individualized treatment programs and increase efficacy of interventions. 34 
Zebrafish are a very useful vertebrate model for exploring molecular processes underlying 35 
disease owing to their small size and genetic tractability. Their utility in terms of behavioral 36 
neuroscience, however, hinges on the validation and publication of reliable assays with adequate 37 
translational relevance. Here we report an initial pharmacological validation of a fully automated 38 
zebrafish version of the commonly used 5-choice serial reaction time task (5-CSRTT) using a 39 
variable interval (VI) pre-stimulus interval (PSI). We found that atomoxetine reduced 40 
anticipatory responses (0.6 mg/Kg), while a high dose (4 mg/Kg) methylphenidate increased 41 
anticipatory responses and the number of trials completed in a session. On the basis of these 42 
results, we argue that similar neurochemical processes in fish as in mammals may control 43 
impulsivity, as operationally defined by anticipatory responses on a continuous performance task 44 
such as this, making zebrafish potentially a good model for exploring the molecular basis of 45 
impulse control disorders, and for first-round drug screening.  46 
 47 
Keywords: 5-choice serial reaction time task, zebrafish, impulsivity, addiction, ADHD, 48 
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Introduction 51 
Impulsivity, as operationally defined in terms of anticipatory responding on a continuous 52 
performance task, has been linked to a number of psychiatric diagnoses, including attention 53 
deficit hyperactivity disorder (ADHD) (Urcelay and Dalley 2012; Winstanley et al. 2006), 54 
substance abuse (Dalley et al. 2011; Everitt et al. 2008; Hosking and Winstanley 2011) and 55 
pathological gambling (Alessi and Petry 2003). Despite a recent increase in our understanding of 56 
the neurochemical and neuroanatomical correlates of impulsivity (Caprioli et al. 2013; Dalley 57 
and Roiser 2012), the underlying cellular processes are somewhat less clear.  58 
Zebrafish provide an excellent model for studying the molecular basis of human disease 59 
owing to their prolific breeding, low maintenance costs and genetic tractability (Guo 2004; 60 
Parker and Brennan 2012; Parker et al. 2013a). We previously demonstrated that adult zebrafish 61 
perform well in terms of their general response characteristics (accuracy, anticipatory 62 
responding, omissions) on a 3-choice (Parker et al. 2012a) and later a 5-choice version (Parker et 63 
al. 2013b) of the commonly used 5-CSRTT (Carli et al. 1983; Robbins 2002) for rodents. 64 
Impulsivity, as operationalized by the rate of anticipatory responding on the task, is a strong 65 
predictor for compulsive drug seeking (Belin et al. 2008) and relapse following withdrawal from 66 
drugs (Economidou et al. 2009). Understanding the cellular and molecular basis of impulsivity 67 
may help us to develop individualized treatment for recovering addicts, but also potentially to 68 
design early interventions for at-risk individuals.  69 
In the present paper, we carried out an initial pharmacological validation of the 5-CSRTT 70 
in adult zebrafish using drugs that have previously been shown to affect rodents’ performance on 71 
the task with well-defined and frequently replicated results. Methylphenidate is a dopamine and 72 
noradrenaline reuptake inhibitor, and has long been used to treat the symptoms of ADHD 73 
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(Barkley 1997), but its effects on anticipatory responding in the 5-CSRTT are less clear with 74 
some studies showing increases in anticipatory response, and some decreases, at various doses 75 
(Bizarro et al. 2004; Navarra et al. 2008). Atomoxetine (Tomoxetine hydrochloride, LY 139603) 76 
is a selective noradrenaline reuptake inhibitor, which has also been successfully used in the 77 
treatment symptoms of ADHD (Michelson et al. 2001). Atomoxetine has shown high efficacy in 78 
reducing anticipatory responding on the 5-CSRTT in rodents (Economidou et al. 2011; 79 
Economidou et al. 2012; Fernando et al. 2012; Robinson et al. 2008). We incubated adult 80 
zebrafish in different doses of each of the drugs prior to probing anticipatory response rates on 81 
the 5-CSRTT using variable interval (VI) pre-stimulus intervals (PSI).  82 
 83 
Method 84 
Subjects 85 
Nineteen adult, mixed-sex, wild-type (TU strain) zebrafish were bred in our aquarium 86 
facility at Queen Mary University of London (QMUL), and reared up to four months of age 87 
according to established protocols (Westerfield 1993). At four months, the fish were moved into 88 
our behavioral testing facility and pair-housed (26-28ºC, 160 lx ambient lighting; 14/10 hr 89 
light/dark cycle) for 1-week prior to commencing the experiment. They remained pair housed 90 
throughout the experimental period. Throughout the experiment, all fish were fed live brine 91 
shrimp and flake food at weekends, and brine shrimp liquidized with bloodworm during testing 92 
(see below) supplemented with commercial dried flake food in the evening after testing. All 93 
procedures were carried out in accordance with the Animals (Scientific Procedures) Act of 1986, 94 
and local ethical guidelines. 95 
 96 
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Apparatus 97 
[FIGURE 1 ABOUT HERE] 98 
 99 
 The fish were trained in a custom-built testing arena (Figure 1) manufactured in-house at 100 
QMUL (Parker et al. 2013b). Briefly, the entire length of the testing unit was 36cm, split into 101 
two halves by the gate (21cm from food area to gate, 15cm from gate to stimulus areas). The gate 102 
is used in order to signal the start and end of trials, and to ensure that all of the fish start each 103 
trial from the same vantage point. In the rodent version of the task, the box is smaller in 104 
comparison to the size of the animal. We have attempted to use a smaller box in previous 105 
implementations of this task, but the fish do not perform well if confined to small spaces. The 106 
external tank (W x L x H: 42cm x 49cm x 15cm) was purchased commercially (Ikea, UK). The 107 
base was constructed from 10mm clear cast acrylic and drilled to fix two uprights to support the 108 
gate mechanism. The testing unit was constructed from opaque acrylic, and a 96-channel i-o card 109 
drove the actuators (National Instruments, Austin, TX). The apparatus were controlled via a 110 
program written in LabView (National Instruments, Austin, TX) that also collected the data 111 
during training sessions. The gate was operated via a pneumatic cylinder (RS Components, UK). 112 
The movements of the fish in the tank, and hence the actuation of the hardware, was performed 113 
by a custom-written (Python) camera-based fish detection system. The cameras were located 114 
above the tanks (Windows LifeCam HD). Food delivery was controlled by a linear stepper motor 115 
(RS Components, UK), calibrated to deliver ~10µl liquidized bloodworm/brine shrimp mixture 116 
via a syringe and a length of 1mm catheter tubing.  The stimuli at the stimulus end of the tank 117 
comprised five super-bright yellow LEDs (RS components, UK) and the stimulus in the 118 
magazine area comprised a single super-bright green LED. 119 
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 Atomoxetine (Tomoxetine hydrochloride, Tocris Bioscience, Bristol, UK; 0.5µM 120 
[0.15mg/Kg], 1µM [0.3mg/Kg], and 2µM [0.6mg/Kg]) and methylphenidate (Threo-121 
methylphenidate hydrochloride, Tocris Bioscience, Bristol, UK; 5µM [1.3mg/Kg], 10µM 122 
[2.6mg/Kg], and 15µM [4mg/Kg]) were dissolved in aquarium-treated water and administered to 123 
each fish at three different doses via incubation in the drug solution for 30-minutes prior to 124 
testing. The incubation tank was a 1-liter transparent acrylic tank, identical to the fishes’ housing 125 
tanks, located adjacent to the testing tanks.  126 
 127 
Procedure 128 
 Prior to training, all fish were acclimated to the behavioral testing room for one week 129 
(Week 0). All testing sessions lasted for 30-minutes, and were carried out Monday-Friday. The 130 
time of day that the fish were tested was staggered to avoid potential diurnal performance 131 
confounds, but the tank in which each fish was tested remained the same for every session. In the 132 
first week of pre-training (Week 1), the fish were habituated to the testing tanks. During this 133 
time, all of the lights remained illuminated and the gate was raised. Food was delivered 134 
intermittently according to a 1-minute fixed time (FT) schedule following entry to the food 135 
magazine. In the second week of pre-training (Week 2), the fish were ‘magazine trained’.  136 
During this phase, the gate was closed and the fish was isolated in the food-delivery end of the 137 
tank. The magazine light was illuminated for up to 30-seconds (1-minute inter-trial interval; ITI), 138 
or until the fish entered the food magazine. Correct entries (i.e., entry during the stimulus 139 
exposure) were reinforced in a discrete trial manner (see above). Entries during the ITI were 140 
neither reinforced nor punished. In the third and final week of pre-training (Week 3), the fish 141 
were trained to approach the stimulus lights at the far end of the tank. At the start of a session, 142 
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the fish was isolated in the food delivery area of the tank, with the magazine light illuminated. 143 
Entry to the magazine started the session. After an ITI of 20-seconds, the gate was raised to 144 
reveal the stimulus apertures. All LEDs were illuminated contiguously for 1-mintue. During this 145 
time, entry to any of the stimulus apertures was conditionally reinforced by illumination of the 146 
magazine light. As the fish swam past the gate it was lowered, and entry to the food magazine 147 
was reinforced. The following trial began after a 20-second ITI. Late entries were not reinforced 148 
or punished, but the fish was isolated in the food delivery area following re-entry for a 20-second 149 
ITI.  The fish were then trained on the 5-CSRTT. The general procedure was as in Week 3, but 150 
only one stimulus light was illuminated at any one time, and we introduced a pre-stimulus 151 
interval (PSI), which represented the delay between the gate being raised and the stimulus being 152 
illuminated.  153 
 Training was split into three distinct phases. The criterion for moving from each phase to 154 
the next was that the fish performed ≥ 20 trials in each session for a minimum of three 155 
consecutive days. In the first phase (weeks 4-5), the stimulus duration was 30-seconds, and the 156 
pre-stimulus interval (PSI) was 1-second (FI schedule). In the second phase (weeks 6-9), the 157 
stimulus duration remained at 30-seconds, but the pre-stimulus interval changed to a 5-second 158 
variable interval (VI) schedule. The third phase (weeks 10-15) incorporated the drug trials. 159 
Atomoxetine was administered at 0.5µM, 1µM, and 2µM, and methylphenidate at 5µM, 10µM, 160 
and 15µM. These dose ranges were based on previous work with rodents (Bizarro et al. 2004; 161 
Economidou et al. 2011; Fernando et al. 2012; Milstein et al. 2010; Navarra et al. 2008; 162 
Robinson et al. 2008) and with zebrafish (Lange et al. 2012). During each drug treatment week, 163 
the treatment schedule was as follows: Monday – baseline; Tuesday – drug; Wednesday-164 
Thursday – baseline; Friday – drug. This allowed for a minimum of two days of washout 165 
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between drug treatments. Each fish received all doses of both drugs twice during the course of 166 
the experiment, with each fish receiving the same drug twice in the same week. The order in 167 
which the drugs and doses were given was counterbalanced between fish to avoid any possibility 168 
of order effects. Performance parameters were calculated as thus: 169 
accuracy = correct/(correct + incorrect) 170 
anticipatory = early/(correct + incorrect + early) 171 
omissions = omissions/(correct + incorrect + early +omissions) 172 
 173 
 Finally, data were analyzed using general or generalized linear mixed effects models 174 
(LME), fit by restricted maximum likelihood (REML) with drug as a fixed effect with seven 175 
levels (Baseline, Methylphenidate: 5µM, 10µM, 15µM, Atomoxetine: 0.5µM, 1µM, 2µM), and 176 
fish ID (random intercept) and day as scalar random effects, followed by pairwise comparisons 177 
(Least Significant Difference; LSD). We used two drug days for each fish specifically as the 178 
fishes’ performance on the task is far more variable than that of rodents. So, each drug was given 179 
twice in the same week and we employed a mixed effects model to deal with any issues of inter-180 
class correlations and pseudoreplication.  181 
Fixed effects were evaluated initially with compound symmetry assumed, and 182 
subsequently with diagonal, first-order autoregressive (AR1) or unstructured covariance 183 
structures. The best fitting model was ascertained by comparisons of Akaike’s Information 184 
Criterion (AIC).  Denominator degrees of freedom were estimated according to the Satterthwaite 185 
approximation. Data were analyzed in IBM® SPSS® Statistics (Version 21 for Macintosh). All 186 
test statistics were evaluated with respect to an α-level of 0.05. All descriptive statistics are 187 
reported as mean ± standard error.  188 
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 189 
Results 190 
 [FIGURE 2 ABOUT HERE] 191 
 Figure 2 displays the learning curves during the first (1-sec FI PSI) and second (5-sec VI 192 
PSI) learning phases. As is clear, all fish increased their response accuracy during the course of 193 
the training, and this continued after the introduction of the 5-sec VI PSI. This was confirmed 194 
with a general LME comparing the first and second phase of learning (1-sec FI PSI vs 5-sec VI 195 
PSI), F 1,696 = 34.38, p < 0.001. There was also a significant increase in anticipatory responses, F 196 
1,724 = 588.01, p < 0.001, and omissions, F1, 725 = 7.54, p < 0.01, upon introduction of the 5-sec VI 197 
PSI. Finally, with respect to approach latency, there was no significant difference between the 198 
first and second phases of the experiment, F 1,439 = 2.79, p = 0.1 (Phase 1 = 3.6±1.42 secs vs. 199 
Phase 2 = 3.42±1.11 secs), nor was there a difference for return latency, F 1,335 = 1.23, p = 0.27 200 
(Phase 1 = 12.61±1.34 secs vs Phase 2 = 12.15±0.93 secs). 201 
 202 
Stability of baseline 203 
[FIGURE 3 ABOUT HERE] 204 
 Drug testing did not commence until the fish were performing ≥ 20 trials in a session. 205 
Prior to drug testing we examined performance over the final 5 sessions of pre-testing to ensure 206 
stability. A linear mixed effects model with day as the fixed effect revealed that accuracy had 207 
stabilized prior to drug testing commencing, F 4,83 = 1.95, p = 0.11, as had anticipatory 208 
responding, F < 1. Omission errors, however, were not stable, F 4,83 = 4.97, p < 0.01. Stability 209 
during the baseline days of drug training was confirmed for anticipatory responding, F 11,181 = 210 
ATOMOXETINE AND ANTICIPATORY RESPONDING IN ZEBRAFISH  
 12 
1.14, p = 0.33. However accuracy, F 11,181 = 3.38, p < 0.01 and omission errors, F 11,179 = 2.46, p < 211 
0.01 were variable during baseline (see Figure 3).   212 
 213 
Training 214 
[FIGURE 4 ABOUT HERE] 215 
Figure 4 displays the number of trials, accuracy, anticipatory responding, omissions, 216 
correct latency and return latency during the drug phase. There was a significant effect of drug 217 
treatment on total number of trials completed (generalized LME with Poisson distribution), F 6, 218 
378 = 2.32, p < 0.05. Post-hoc pairwise comparisons confirmed a dose-dependent change for 219 
methylphenidate treatment. There was a significant increase in trials between baseline and 15µM 220 
methylphenidate (p = 0.041), but no differences between baseline and 10µM (p = 0.14) or 5µM 221 
(p = 0.18), nor between methylphenidate doses (ps > 0.65). There was no difference between 222 
baseline and atomoxetine at any of the doses (ps > 0.22) nor between atomoxetine doses (ps > 223 
0.89).  224 
Drug treatment had no significant effect on proportion of correct responses during 225 
sessions, F < 1. There was a significant main effect of drug treatment on anticipatory responses, 226 
F 6, 363 = 2.64, p < 0.05. Pairwise comparison revealed that atomoxetine had a dose-dependent 227 
effect. Specifically, 2µM atomoxetine reduced anticipatory responses relative to baseline  (p < 228 
0.01), but neither 1µM nor 0.5µM atomoxetine had any effect (ps > 0.23). There was no 229 
difference between 2µM, 1µM or 0.5µM atomoxetine (ps > 0.13). Methylphenidate also affected 230 
anticipatory responding, increasing it relative to baseline at 15µM (p < 0.5). There were no 231 
differences at 5µM or 10µM compared to baseline (ps > 0.25). The fish also performed 232 
significantly more anticipatory responses at 15µM methylphenidate than at 10µM (p < 0.05), but 233 
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no difference between 15 and 5µM (p = 0.2). There was no effect of drug treatment on 234 
omissions, F 6,361 = 1.68, p = 0.12, or approach latency, F < 1, or return latency, F 6,109 = 1.86, p 235 
= 0.09. 236 
 237 
Discussion 238 
The aim of the present study was to carry out an initial pharmacological validation of a fully 239 
automated version of the 5-CSRTT for studying impulse control in zebrafish. We previously 240 
demonstrated that a low dose of amphetamine (0.025 mg/kg) reduced anticipatory responding 241 
relative to saline injection on a 3-choice version of this task (Parker et al. 2012a). Here, we show 242 
that atomoxetine reduced anticipatory responding in a dose-dependent manner (2µM 243 
[0.6mg/Kg]), and methylphenidate increased anticipatory responding at higher doses (15µM 244 
[4mg/Kg]). Methylphenidate also increased the number of trials completed during training 245 
sessions, suggesting increased general activity levels following exposure to higher doses of this 246 
drug. Neither compound had an effect on performance accuracy or omissions, nor any aspect of 247 
response latency at the doses tested here. However, performance of zebrafish was variable during 248 
baseline in terms of omission errors and to a lesser extent, accuracy, suggesting that the present 249 
manifestation of this task may not be suitable for addressing attentional performance. Our data 250 
show that in fish, selective increases in noradrenergic activity increase the ability to withhold a 251 
response on this task representing similar patterns to those observed in rats (Robinson et al. 252 
2008) and human patients with ADHD (Chamberlain et al. 2007). This suggests some degree of 253 
conservation of the neurobiological underpinnings of the ability to withhold a response across 254 
species.  255 
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 We also observed a higher proportion of anticipatory responses following incubation in 256 
the maximum dose of methylphenidate (15µM), and intensification of general activity at all 257 
doses, the latter as evidenced by the significant increase in completed trials in a session. The 258 
increase in anticipatory responding and the increase in general activity levels are similar to those 259 
observed in rats following comparably high doses of methylphenidate (5 mg/kg; Navarra et al. 260 
2008) and amphetamine (Cole and Robbins 1987; 1989). Methylphenidate blocks both the 261 
norepinephrine and dopamine transporter, thus causing a general increase in catecholamine 262 
neurotransmission (Bymaster et al. 2002). The fact that methylphenidate did not reduce 263 
anticipatory responding in the fish at the lower doses used here may suggest that the doses used 264 
here may not have been appropriate for this species. This hypothesis is partially supported by the 265 
fact that in a previous study we found that a very low dose of amphetamine (0.025mg/Kg), a 266 
similar catecholaminergic transporter blocker, reduced anticipatory responding relative to saline 267 
injection (Parker et al. 2012a). However, we based the doses here on previous work with larval 268 
zebrafish (Lange et al. 2012) as well as effective doses used in mammalian models (Bizarro et al. 269 
2004). In addition, the effect of methylphenidate on anticipatory responses on the 5-CSRTT are 270 
highly variable, with some studies finding increases (Milstein et al. 2010; Navarra et al. 2008), 271 
some no effect (Fernando et al. 2012) and some decreases (Bizarro et al. 2004) even at 272 
comparable doses to one another (2.5-10mg/kg).  273 
 Zebrafish share a large degree of homology with mammals with respect to 274 
catecholaminergic and monoaminergic neurotransmitter systems (Parker et al. 2013a). 275 
Functional homologues for midbrain regions related to impulsivity are present in zebrafish, such 276 
as the caudal raphe complex (Rink and Wullimann 2002), from which serotoninergic (5-HT) 277 
neurons project to the dorsal pallium (fish) and pre-frontal regions (mammals). It is also clear 278 
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that both dopamine (DA) and 5-HT projections from the pallium to thalamic regions are very 279 
similar to those seen in mammals (Guo et al. 1999; Holzschuh et al. 2001; Rink and Guo 2004; 280 
Rink and Wullimann 2001; 2002). Of relevance to this study, zebrafish have strikingly similar 281 
projection patterns of catecholaminergic neurons; for example, norepinephrine neural projections 282 
from the locus coeruleus to the subpallium in zebrafish and to the cortex in mammals (Holzschuh 283 
et al. 2001; Korf et al. 1973; Ma 1997; Tay et al. 2011). The currently accepted hypothesis is that 284 
the route of action of both atomoxetine and methylphenidate is via the reduction of locus 285 
coeruleus activity (Pliszka et al. 1996). In addition, atomoxetine (1µM) and methylphenidate 286 
(10µM) rescued the hyperactive/motor-impulsive phenotype observed in a putative ADHD 287 
model using morpholino oligonucleotide-treated zebrafish larvae with a transient loss of function 288 
in the latrophilin 3 (lphn-3) gene (Lange et al. 2012). This, in conjunction with our findings that 289 
adult zebrafish respond similarly to atomoxetine in terms of anticipatory responding on a 5-290 
CSRTT to mammalian models and humans, suggest that this species may represent a useful 291 
model system for examining the cellular and molecular basis of psychiatric disorder linked to 292 
impulse control and for first round drug screening.   293 
 There are a number of performance, task-related and methodological differences between 294 
fish and mammals on this task that should be addressed here. First, the proportion of correct 295 
responses is lower in fish (~60% at asymptote) than rodents (~80-90% at asymptote) and the 296 
response and return latencies are much longer in fish (~5 sec in fish vs. ~1 sec in rodents). In 297 
addition, stability of baseline responding in terms of accuracy and omission errors appears to be 298 
difficult to attain in fish. It may be that further refinement of the procedure will improve this in 299 
the future, or it may reflect specific differences in task-performance between the species. For 300 
example, fish may become satiated faster than rodents owing to their size and the amount of food 301 
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deliverable in each trial. If this were the case we may expect the rate of omission errors to be 302 
correlated with accuracy, which we did not observe when all baseline sessions were considered. 303 
However, in the final three baseline sessions, where accuracy increases (see Fig. 3a), omissions 304 
increased in a similar manner consistent with the satiety hypothesis. Previously, we found 305 
omission and accuracy to be correlated (Parker et al. 2012a). Alternatively, it may be that fish do 306 
not stay on-task in the same way as rodents, meaning that they may not be capable of sustaining 307 
attention for prolonged periods. This would result in lower reliability for accuracy and omission 308 
errors, but will not necessarily affect premature responding as this aspect of performance would 309 
be related to trial-specific motivation to approach the stimulus aperture.  310 
There is some evidence that fish have differences in cognitive capacity; for example a 311 
number of studies in the 1960s suggested that fish did not form attentional sets (Behrend et al. 312 
1965; Bitterman 1965; Bitterman and Mackintosh 1969). However, this has since been shown to 313 
be have been the result of poorly defined task-parameters (Parker et al. 2012b; Woodward et al. 314 
1971). Second, the duration of the stimuli are shorter in the rodent version (~0.5-sec) than in fish 315 
(30-sec) (Bari et al. 2008). We are unable to test fish at shorter stimulus durations, in particular 316 
because zebrafish will become very stressed and not perform if confined to small areas. As such, 317 
our testing tank is far larger in size relative to the size of the fish than the rodent assay. Therefore 318 
we are not claiming that this task will be suitable for measuring aspects of attention in the fish 319 
under the current protocol, but we hope that in the future, this might be incorporated into the 320 
assay. Finally, in our design we incorporate a start gate in the apparatus. In the classical design of 321 
the 5-CSRTT, the animal is required to perform a nose-poke the magazine and turn around to 322 
start a trial. In our version, the fish has to return to the start area in order to drop the gate, and 323 
subsequently re-start the task. In this sense, both versions rely on the animal performing an 324 
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observing-response in order to gain access to the task stimuli. We have found that what appear to 325 
be pre-potent responses in the fish can be induced by a variable interval pre-stimulus delay. 326 
Furthermore we can, to some extent, control this with a noradrenaline transporter blocker 327 
(atomoxetine), in a similar manner to that consistently observed in rodents. We would argue 328 
therefore that this study represents a useful starting point for future research. 329 
Zebrafish offer a valuable model for studying the genetics and molecular basis of 330 
psychiatric disease in general (Guo 2004). There are numerous ethical and practical difficulties 331 
relating to GWAS and CNV studies in humans, including an inability to test cause/effect 332 
relations. This has led to the extensive use of animal models, often examining phenotypes 333 
retrospectively using reverse-genetic procedures such as knock out/knock down of candidate 334 
genes in murine models. Forward genetic screening procedures that use mutagenesis to introduce 335 
random variation into the genome complement these studies and can uncover novel alleles and 336 
pathways contributing to specific disease phenotypes (Muto et al. 2005). Mutagenesis studies in 337 
rodents have been limited by both ethical and practical considerations, not least of which is the 338 
small number of offspring in each generation (rodents have 5-10 offspring per pairing in 339 
comparison to the 200-300 obtained from fish) and because levels of chemical mutagens 340 
required to induce the high density of mutations per genome seen in zebrafish (1/300kb) are not 341 
tolerated by rodents. In contrast, mutagenesis screening in zebrafish has been used to great effect 342 
to uncover genetic modifiers of developmental processes (Amsterdam et al. 1999; Amsterdam et 343 
al. 2004; Darland and Dowling 2001; Golling et al. 2002).  The data we have described here 344 
allow for behavioural screening in adult zebrafish to identify genetic modifiers of impulse 345 
control. 346 
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In summary, we have demonstrated that wild-type adult zebrafish show reduced 347 
anticipatory responding on the 5-CSRTT with a comparable dose of atomoxetine (2µM) to those 348 
observed in mammals. Taken with previous data from our lab (Parker et al. 2012a) and from 349 
larval models of ADHD (Lange et al. 2012), this highly tractable and useful system, zebrafish, is 350 
emerging as a potentially useful model for studying the cellular basis of impulsivity and for first-351 
round drug screening. 352 
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Figure legends: 506 
 507 
 508 
Figure 1. Testing environment used to train zebrafish on 5-CSRTT. a) Gate mechanism, 509 
controlled by pneumatic piston. The gate raised to reveal the stimulus area containing the 510 
stimulus apertures, b), and the food delivery area containing the food magazine, c). The correct 511 
stimulus aperture, b), was  signalled by illuminating a super-bright yellow LED, and food 512 
availability was signalled in the food magazine, c), by illuminating a super-bright green LED. 513 
Food, liquidized bloodworm and brine shrimp, was delivered via a 2ml plastic syringe, e), driven 514 
by a linear stepper motor, d), all mounted on an acylic base. Image detection was carried out 515 
using custom software (Python) and an HD webcam from above the tanks.  (Figure reproduced, 516 
with permission, from Parker et al., 2013b). 517 
 518 
 519 
Figure 2. Training data from Phase 1 (1-sec FI PSI) and Phase 2 (5-sec VI PSI) of 5-CSRTT. 520 
Criterion for moving from Phase 1 to Phase 2 was ≥ 20 trials per session for three consecutive 521 
sessions. A) Correct responses increased steadily thoughout training, and significantly increased 522 
between phases 1 and 2. B) Anticipatory responses increased on initiation of the 5-sec VI PSI. C) 523 
Omission errors increased significantly in phase 2. D) Summary of data in each training phase. 524 
Error bars represent SEM. Note: ** p < 0.01, post-hoc pairwise comparisons. 525 
 526 
 527 
Figure 3. Performance stability during baseline sessions of drug-trials. There was variability in 528 
accuracy (A), with accuracy increasing significantly in the last three days of baseline (days 58-529 
61). There was also variability in omission errors (C), with omission error decreasing during 530 
days 51-58 of the drug delivery period, but re-stabilizing thereafter. Anticipatory response rate 531 
(B) was stable throughout the drug period. Error bars represent SEM. Note: Differs from Day 41 532 
* p < 0.05; ** p < 0.01, post-hoc pairwise comparisons. 533 
 534 
 535 
Figure 4. Dose-related effects of atomoxetine and methylphenidate on performance parameters 536 
of zebrafish in 5-CSRTT. A) Total trials in a session increased significantly (compared to 537 
baseline) following 15µM methylphenidate, but not at any other dose of either drug; B) 538 
Accuracy (proportion of correct responses) was not affected by either drug; C) Proportion of 539 
anticipatory responses was reduced (relative to baseline) following exposure to 2µM 540 
atomoxetine and increased following exposure to 15µM methylphenidate ; D) Proportion of 541 
omission errors was not affected by either drug; E) Approach latency and F) return latency to 542 
collect food were also unaffected by either drug. Error bars represent SEM. Note: Differs 543 
significantly from baseline * p < 0.05; **p < 0.01, post-hoc pairwise comparisons. 544 
